1Griendling KK,Sorescu D,Ushio-Fukai M.NAD (P)H oxidase:role in cardiovascular biology and disease.Circ Res,2000; 86:494-501
2Kasuga M.Insulin resistance and pancreatic B cell failure.J Cli Invest,2006; 116:1756-1760
3Inoguchi T,Nawata H et al.Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes:role of vascular NAD (P) H oxidase.J Am Soc Nephrol,2003; 14:S227-S232
4Lowell BB,Shulman GI.Mitochonrial dysfunction and type 2 diabetes.Science,2005; 307:384-387
5Festa A,D' Agostino RJr,Tracy RP et al.Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes:the Insulin Resistance Atherosclerosis Study.Diabetes,2002; 51:1131-1137
6Lee HB,Yu MR,Yang Y et al.Reactive oxygen species -regulated signaling pathways in diabetic nephropathy.J Am Soc Nephrol,2003; 14:S241-S245
7Francesco P.Pathogenetic mechanisms of diabetic nephropathy.J Am Soc Nephrol,2005; 16:30-33
8Vecchione C et al.Selective rac-1 ihibition protects from diabetes-induced vscular injury.Circulation Research,2006; 98:218
9Talior I et al.PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice:role for NADPH oxidase.Am J Physiol Endocrinol Metab,2005; 288:E405-E411
10Jamie R et al.AT1 blockade pevents glucose-induced cardiac dysfunction in ventricular myocytes.Hypertension,2003; 42:206
